- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02085954
Evaluation of a Training in the Walking With Exosquelette (LOKOMAT)
March 1, 2016 updated by: Nicolas ROCHE, Centre d'Investigation Clinique et Technologique 805
Stroke patients in the investigators rehabilitation unit follow gait trainings with robotic-assistive devices such as Lokomat.
Patients able to walk alone are also assessed with 3D gait analysis.
The objective of this study is to assess the effects of gait training in Lokomat on biomecanic gait parameters in stroke patients.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
13
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Garches, France, 92380
- Hôpital Raymond Poincaré
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
stroke patients follow in our rehabilitation hospital, able to walk alone
Description
Inclusion Criteria:
- single stroke
- able to walk alone
- > 18years
Exclusion Criteria:
- Cognitive impairments disturbing understanding
- Uncontrolled medical disorder associated
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
peak knee flexion (degrees)
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 week
|
participants will be followed for the duration of hospital stay, an expected average of 1 week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
hip and ankle kinematics (degrees)
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 week
|
participants will be followed for the duration of hospital stay, an expected average of 1 week
|
|
kinetics (newton/meter)
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 week
|
participants will be followed for the duration of hospital stay, an expected average of 1 week
|
|
spatio temporal parameter (m/s)
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 week
|
participants will be followed for the duration of hospital stay, an expected average of 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (ACTUAL)
December 1, 2015
Study Completion (ACTUAL)
December 1, 2015
Study Registration Dates
First Submitted
January 28, 2014
First Submitted That Met QC Criteria
March 11, 2014
First Posted (ESTIMATE)
March 13, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
March 2, 2016
Last Update Submitted That Met QC Criteria
March 1, 2016
Last Verified
October 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 12077 (Korea FDA)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany